Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma

Clinical trial NCT06017297 · WITHDRAWN

Trial details

NCT number: NCT06017297
Sponsor: Georgetown University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Borderline Resectable Carcinoma Biliary Tract Cancer

Start date: 2024-12-01
Primary completion: 2026-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.